Intrarenal renin–angiotensin system activity is augmented after initiation of dialysis

Augmented circadian rhythm of the intrarenal renin–angiotensin systems in anti-thymocyte serum nephritis rats

(2016) Shinsuke Isobe et al.   HYPERTENSION RESEARCH

The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy

(2015) Atsuhisa Sato   HYPERTENSION RESEARCH

Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage

(2014) Shinsuke Isobe et al.   Clinical and Experimental Nephrology

Tolvaptan increases urine and ultrafiltration volume for patients with oliguria undergoing peritoneal dialysis

(2013) Tohru Iwahori et al.   Clinical and Experimental Nephrology

Liver Angiotensinogen Is the Primary Source of Renal Angiotensin II

(2012) T. Matsusaka et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Addition of Angiotensin II Type 1 Receptor Blocker to CCR2 Antagonist Markedly Attenuates Crescentic Glomerulonephritis

(2011) Maki Urushihara et al.   HYPERTENSION

Angiotensin II receptor blocker partially ameliorated intrarenal hypoxia in chronic kidney disease patients: a pre-/post-study

(2011) K. Manotham et al.   INTERNAL MEDICINE JOURNAL

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

ROLE OF ACTIVATED INTRARENAL REACTIVE OXYGEN SPECIES AND RENIN-ANGIOTENSIN SYSTEM IN IgA NEPHROPATHY MODEL MICE

(2009) Naro Ohashi et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

SEQUENTIAL ACTIVATION OF THE REACTIVE OXYGEN SPECIES/ANGIOTENSINOGEN/RENINANGIOTENSIN SYSTEM AXIS IN RENAL INJURY OF TYPE 2 DIABETIC RATS

(2008) Kayoko Miyata et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases

(2008) Hiroyuki Kobori et al.   Journal of the American Society of Hypertension